Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$4.56B |
| 2 |
Intel
INTC
|
+$2.34B |
| 3 |
Union Pacific
UNP
|
+$1.18B |
| 4 |
Norfolk Southern
NSC
|
+$992M |
| 5 |
Wells Fargo
WFC
|
+$789M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$817M |
| 2 |
Amazon
AMZN
|
+$782M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$618M |
| 4 |
Altria Group
MO
|
+$610M |
| 5 |
Intuit
INTU
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.14% |
| 2 | Technology | 12.09% |
| 3 | Industrials | 11.31% |
| 4 | Communication Services | 11.1% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ultragenyx Pharmaceutical
RARE
$2.65B
| $450M | 0.15% |
4,398,068
+122,982
| +3% | +$9.55M |
|
152
Sprouts Farmers Market
SFM
$8.03B
| $432M | 0.14% |
15,995,926
+3,620,000
| +29% | +$111M |
|
|
BRCM
153
DELISTED
BROADCOM CORP CL-A
BRCM
| $430M | 0.14% |
8,360,000
+1,981,344
| +31% | +$96.4M |
|
154
Zebra Technologies
ZBRA
$17.9B
| $429M | 0.14% |
3,866,302
| – | – |
|
155
FirstEnergy
FE
$27.2B
| $424M | 0.14% |
13,019,276
-6,826,825
| -34% | -$239M |
|
156
Arista Networks
ANET
$265B
| $419M | 0.14% |
82,078,752
+4,458,384
| +6% | +$19.9M |
|
157
Williams-Sonoma
WSM
$28.9B
| $413M | 0.14% |
10,052,000
| – | – |
|
|
MNDT
158
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $411M | 0.13% |
8,393,725
-930,588
| -10% | -$42.2M |
|
159
T-Mobile US
TMUS
$190B
| $407M | 0.13% |
10,510,305
-1,554,695
| -13% | -$55.7M |
|
160
Merck
MRK
$328B
| $407M | 0.13% |
7,496,538
| – | – |
|
|
NBIS
161
Nebius Group N.V.
NBIS
$70.5B
| $405M | 0.13% |
26,594,600
+4,474,600
| +20% | +$81.7M |
|
|
EMC
162
DELISTED
EMC CORPORATION
EMC
| $403M | 0.13% |
15,287,000
-9,082,000
| -37% | -$242M |
|
163
Telus
TU
$15B
| $403M | 0.13% |
23,409,140
+8,784,540
| +60% | +$151M |
|
|
SIX
164
DELISTED
Six Flags Entertainment Corp.
SIX
| $403M | 0.13% |
8,981,400
| – | – |
|
165
Analog Devices
ADI
$187B
| $398M | 0.13% |
6,199,826
| – | – |
|
|
BHI
166
DELISTED
Baker Hughes
BHI
| $389M | 0.13% |
6,305,840
| – | – |
|
167
TechnipFMC
FTI
$29.5B
| $388M | 0.13% |
12,563,876
-3,177,716
| -20% | -$97.8M |
|
168
NOV
NOV
$7.45B
| $388M | 0.13% |
8,029,000
+400,000
| +5% | +$20.6M |
|
169
ITT
ITT
$19.4B
| $383M | 0.13% |
9,163,121
+924,000
| +11% | +$38.5M |
|
|
ATHN
170
DELISTED
Athenahealth, Inc.
ATHN
| $382M | 0.13% |
3,333,523
+21,700
| +0.7% | +$2.59M |
|
|
WBA
171
DELISTED
Walgreens Boots Alliance
WBA
| $381M | 0.13% |
4,511,400
-550,000
| -11% | -$47.4M |
|
172
Melco Resorts & Entertainment
MLCO
$2.14B
| $378M | 0.12% |
19,257,484
| – | – |
|
173
AutoNation
AN
$6.9B
| $378M | 0.12% |
6,000,000
-454,200
| -7% | -$28.8M |
|
174
HP
HPQ
$26.8B
| $372M | 0.12% |
27,293,790
-2,202,000
| -7% | -$32.7M |
|
175
Mastercard
MA
$490B
| $369M | 0.12% |
+3,946,000
| New | +$362M |
|
Similar funds
Capital Research Global Investors's Q2 2015 Portfolio in Review
As of Q2 2015, Capital Research Global Investors held 466 positions worth $304B, up 4.2% from $292B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors deployed $10.5B of net new capital in Q2 2015, opening 26 new positions and adding to 162 existing holdings. Its largest new stake was Enbridge: 11,185,165 shares worth $523M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Johnson Controls International, an estimated $817M trimmed.
- Capital Research Global Investors's largest Q2 2015 buy was Enbridge: 11,185,165 shares worth $523M.
- Capital Research Global Investors added most to Alphabet (Google) Class C in Q2 2015, an estimated $4.56B increase.
- Capital Research Global Investors's biggest Q2 2015 reduction was Johnson Controls International, cutting an estimated $817M.
- Capital Research Global Investors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $618M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $304B portfolio in Q2 2015.
- Capital Research Global Investors opened 26 new positions and closed 33 in Q2 2015.
- Capital Research Global Investors's portfolio value rose 4.2% quarter-over-quarter to $304B.
Based on Capital Research Global Investors's 13F filing for Q2 2015, filed 14 Aug 2015.